Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
The M20 IL-1 inhibitor prevents onset of adjuvant arthritis
Vivian Barak
*
, David Peritt
, Iancu Flechner
, Yoav Sherman
,
Elimelech Okon
, Peter Yanai
, Tal Halperin
, Abraham J. Treves
*
Corresponding author for this work
Hadassah University Medical Centre
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The M20 IL-1 inhibitor prevents onset of adjuvant arthritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant-Induced Arthritis
100%
Adjuvant Arthritis
100%
Rheumatoid Arthritis
75%
Inflammatory Arthritis
75%
Freund's Adjuvant
50%
Inflammation
25%
Tumor Necrosis Factor
25%
Cytokine
25%
Leukocytosis
25%
Lewis Rat
25%
Arthritis
25%
Acute Phase Protein
25%
Chronic Inflammation
25%
Lymphadenopathy
25%
Erythema
25%
Joint Destruction
25%
Joint Swelling
25%
Keyphrases
Adjuvant Arthritis
100%
IL-1 Inhibitors
100%
Interleukin-1β
71%
Rheumatoid Arthritis
42%
Freund Incomplete Adjuvant
28%
Fever
14%
Lewis Rats
14%
Dose Effect
14%
After Injection
14%
Histological Examination
14%
Inhibitory Activity
14%
Pathological Process
14%
Leukocytosis
14%
No Adverse Effect
14%
In Vitro Activity
14%
Footpad
14%
Acute Phase Reactants
14%
Chronic Inflammation
14%
Erythema
14%
Joint Inflammation
14%
Joint Fluid
14%
Lymph Node Enlargement
14%
Joint Swelling
14%
Joint Destruction
14%
Acute Inflammatory Reaction
14%
Periarticular
14%
Myelomonocytic Cells
14%